|
DIMT1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.379040E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.956180E-04 |
| Normal-vs-Stage2 |
4.357400E-03 |
| Normal-vs-Stage3 |
9.639700E-04 |
| Normal-vs-Stage4 |
1.019440E-04 |
| Stage1-vs-Stage2 |
7.183400E-01 |
| Stage1-vs-Stage3 |
9.710800E-01 |
| Stage1-vs-Stage4 |
4.492800E-01 |
| Stage2-vs-Stage3 |
7.233600E-01 |
| Stage2-vs-Stage4 |
8.295600E-01 |
| Stage3-vs-Stage4 |
4.648600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.402110E-04 |
| Normal-vs-AfricanAmerican |
2.515800E-02 |
| Normal-vs-Asian |
8.620700E-04 |
| Caucasian-vs-AfricanAmerican |
8.044600E-01 |
| Caucasian-vs-Asian |
6.438400E-01 |
| AfricanAmerican-vs-Asian |
5.515200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01869999999493E-05 |
| Normal-vs-Female |
5.845200E-04 |
| Male-vs-Female |
1.786420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.383900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.84620000000169E-05 |
| Normal-vs-Age(61-80Yrs) |
1.037070E-03 |
| Normal-vs-Age(81-100Yrs) |
2.347000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.230800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.891200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.956400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.628400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.510800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.670400E-01 |
| Classical-VS-Follicular |
5.058700E-03 |
| Classical-VS-Other |
1.533550E-01 |
| Classical-VS-Normal |
3.601700E-03 |
| Tall-VS-Follicular |
3.396200E-01 |
| Tall-VS-Other |
3.192000E-01 |
| Tall-VS-Normal |
7.521400E-03 |
| Follicular-VS-Other |
6.819200E-01 |
| Follicular-VS-Normal |
3.79580000000601E-05 |
| Other-VS-Normal |
1.122140E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0047000000023E-06 |
| Normal-vs-N1 |
4.519900E-03 |
| N0-vs-N1 |
5.803000E-01 |
|
|
